A glycylcycline antibiotic effective against severe multidrug-resistant infections, including MRSA and VRE.
Glycylcycline antibiotic
200-400 mg/day as a single dose or in 2 divided doses.
Tigecycline 50mg Injection can be used in the treatment of the following conditions:
Tigecycline binds to the 30S ribosomal subunit, halting bacterial protein synthesis and preventing replication.